Avatrombopag, also known as AKR-501, YM477, AS 1670542 or E5501, is a novel orally-active thrombopoietin (TPO) receptor agonist. AKR-501 specifically targeted the TPO receptor and stimulated megakaryocytopoiesis throughout the development and maturation of megakaryocytes just as rhTPO did. AKR-501 may be useful in the treatment of patients with thrombocytopenia.
For research use only. We do not sell to patients.
Chemical Information
Name
Avatrombopag
Iupac Chemical Name
Avatrombopag
Synonyms
AKR501; AKR 501; AKR-501; YM477; YM-477; YM 477; E5501; AS 1670542; AS1670542; AS-1670542; Avatrombopag